Moderna says omicron-specific booster should be ready by August
Jun 23, 2022
The vaccine targets both omicron and the original strain of the virus.
Exercise may boost immune response to flu vaccine
Jun 16, 2022
However, acute exercise does not show a benefit for generally inactive people.
COVID-19 vaccines cut mortality with heart failure
Jun 16, 2022
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.
Vaccine effectiveness against SARS-CoV-2 infection wanes over time
Jun 14, 2022
However, for all ages, vaccine effectiveness against severe COVID-19 was high overall, at 90% five months or longer after two doses.
Durability of mRNA-1273 protection against symptomatic COVID-19 examined
Jun 13, 2022
Among those receiving two doses of the Moderna vaccine, peak vaccine efficacy against symptomatic COVID-19 was estimated to be 94.1% at 120 days after the first dose.
One in nine may get delayed large local reaction after Moderna vaccine
Jun 10, 2022
A higher risk was seen among women and among individuals aged 30 to 69 years.
Vaccination cuts risk of severe COVID-19 in patients on dialysis
Jun 01, 2022
There was a reduction in risk of admission and deaths with prior two-dose vaccination versus no vaccination.
Vaccination offers partial protection for postacute phase of COVID-19
May 31, 2022
Individuals with breakthrough infection have an increased risk for death and postacute sequelae compared with contemporary controls.
Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
Rollout of Pfizer COVID-19 vaccine saved lives, healthcare dollars
May 19, 2022
A model shows the vaccine tied to the prevention of 110,000 deaths and a resulting $30.4 billion direct healthcare cost savings.